Celon Pharma SA (CLN) — Strategic Asset Allocation Index
Celon Pharma SA (CLN) has a Strategic Asset Allocation Index of 74.7% as of June 2023. Strategic assets (PP&E of zł348.38 Million plus long-term investments of zł-) total zł348.38 Million, measured against net assets of zł466.48 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Celon Pharma SA Strategic Asset Allocation Index (2015–2021)
This chart shows how Celon Pharma SA's Strategic Asset Allocation Index has evolved across 7 annual periods from 2015 to 2021. As of June 2023, the index stands at 74.7%, representing strategic assets of zł348.38 Million against net assets of zł466.48 Million PLN. Explore Celon Pharma SA (CLN) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Celon Pharma SA (2015–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Celon Pharma SA from 2015 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Celon Pharma SA market cap and net worth.
| Year | SAAI | Strategic Assets (PLN) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 57.1% | zł316.57 Million | zł316.57 Million | zł- | zł554.00 Million | ▼ -15.1 pp |
| 2020 | 72.2% | zł313.80 Million | zł313.80 Million | zł- | zł434.67 Million | ▲ +20.5 pp |
| 2019 | 51.7% | zł230.08 Million | zł230.08 Million | zł- | zł445.04 Million | ▲ +13.4 pp |
| 2018 | 38.2% | zł171.64 Million | zł171.64 Million | zł- | zł448.73 Million | ▲ +10.7 pp |
| 2017 | 27.6% | zł121.31 Million | zł121.31 Million | zł- | zł439.85 Million | ▼ -0.3 pp |
| 2016 | 27.8% | zł112.08 Million | zł112.08 Million | zł- | zł402.50 Million | ▼ -71.8 pp |
| 2015 | 99.7% | zł100.51 Million | zł100.51 Million | zł- | zł100.82 Million | — |